company background image
301520 logo

Anhui Wanbang Pharmaceutical TechnologyLtd SZSE:301520 Stock Report

Last Price

CN¥41.48

Market Cap

CN¥2.7b

7D

2.4%

1Y

-31.5%

Updated

25 Nov, 2024

Data

Company Financials

Anhui Wanbang Pharmaceutical Technology Co.,Ltd.

SZSE:301520 Stock Report

Market Cap: CN¥2.7b

Anhui Wanbang Pharmaceutical Technology Co.,Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Anhui Wanbang Pharmaceutical TechnologyLtd
Historical stock prices
Current Share PriceCN¥41.48
52 Week HighCN¥63.99
52 Week LowCN¥33.88
Beta0
11 Month Change-7.22%
3 Month Change15.74%
1 Year Change-31.51%
33 Year Changen/a
5 Year Changen/a
Change since IPO-43.95%

Recent News & Updates

Recent updates

Anhui Wanbang Pharmaceutical Technology (SZSE:301520) Is Posting Solid Earnings, But It Is Not All Good News

Apr 26
Anhui Wanbang Pharmaceutical Technology (SZSE:301520) Is Posting Solid Earnings, But It Is Not All Good News

Shareholder Returns

301520CN Life SciencesCN Market
7D2.4%-4.4%-2.1%
1Y-31.5%-32.3%2.8%

Return vs Industry: 301520 matched the CN Life Sciences industry which returned -32.3% over the past year.

Return vs Market: 301520 underperformed the CN Market which returned 2.8% over the past year.

Price Volatility

Is 301520's price volatile compared to industry and market?
301520 volatility
301520 Average Weekly Movement8.2%
Life Sciences Industry Average Movement10.6%
Market Average Movement8.4%
10% most volatile stocks in CN Market12.7%
10% least volatile stocks in CN Market5.7%

Stable Share Price: 301520 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 301520's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
2006479Chunlei Taowww.ahwbyy.cn

Anhui Wanbang Pharmaceutical Technology Co.,Ltd. provides drug research and development and clinical trial services for drug manufacturers and marketing authorization holders in China. The company was founded in 2006 and is based in Hefei, China.

Anhui Wanbang Pharmaceutical Technology Co.,Ltd. Fundamentals Summary

How do Anhui Wanbang Pharmaceutical TechnologyLtd's earnings and revenue compare to its market cap?
301520 fundamental statistics
Market capCN¥2.70b
Earnings (TTM)CN¥108.58m
Revenue (TTM)CN¥394.46m

25.5x

P/E Ratio

7.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
301520 income statement (TTM)
RevenueCN¥394.46m
Cost of RevenueCN¥224.16m
Gross ProfitCN¥170.30m
Other ExpensesCN¥61.72m
EarningsCN¥108.58m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.63
Gross Margin43.17%
Net Profit Margin27.53%
Debt/Equity Ratio0%

How did 301520 perform over the long term?

See historical performance and comparison

Dividends

1.2%

Current Dividend Yield

31%

Payout Ratio